A gene test that predicts which cancer drugs will be most effective for different people is to be trialled by Duke University researchers.

The test scans thousands of genes from a patient’s tumor to produce a genomic profile of the cancer’s molecular makeup.

It could also save lives and reduce patients’ exposure to the toxic side effects of chemotherapy drugs.